Simultaneous Acute Cardio-Cerebral Infarction: A Rare Case Report Experience in Type C Hospital in Indonesia

Nurlita Asri Andriani; Arjatya Pramadita Mangkoesoebroto; Rizkia Chairina Yuliandita; Bayu Hendro Pramudyo

doi:10.11594/ibehs.vol13iss2pp41-47

Authors

Nurlita Asri Andriani Muhammadiyah Islamic Hospital of Kendal, Central Java, Indonesia
Arjatya Pramadita Mangkoesoebroto Department of Cardiology and Vascular Disease, Muhammadiyah Islamic Hospital of Kendal
Rizkia Chairina Yuliandita Siti Khodijah Hospital, Pekalongan
Bayu Hendro Pramudyo Maguan Husada Hospital, Wonogiri

DOI:

https://doi.org/10.11594/ibehs.vol13iss2pp41-47

Keywords:

cardio-cerebral infarction, anticoagulant, STEMI, hypertension, PCI

Abstract

Background: The simultaneous occurrence of ST-elevation myocardial infarction (STEMI) and acute ischemic stroke (AIS) was described as Cardio-Cerebral Infarction. Consequently, we aimed to provide an overview of the available treatment option for patients in type c hospital in order to guide the similar cases.

Case Description: A 50-year-old man came to the emergency room complaining of chest pain for two hours before. The patient had a history of hypertension and an active smoker. The patient had a left hemiparesis. The patient's electrocardiogram showed ST segment elevation in leads V3 and V4. A non-contrast head CT-scan showed infarct in the right occipital region. Echocardiogram showed regional wall motion abnormality. The patient was admitted to the hospital, administered DAPT, statin, anticoagulant and discharged after relief of symptoms. Intravenous alteplase followed by primary PCI is the gold standard therapy. However, due to limitation, anticoagulants were chosen and showed clinical improvements.

Conclusion: In summary, the goal for treat CCI is to achieve more efficacy therapy while minimising the risk of bleeding. Despite the limitations, patient outcome was good.

References

Akinseye, O. A. et al. (2018) ‘Simultaneous acute cardio-cerebral infarction: is there a consensus for management?’, Annals of Translational Medicine, 6(1), pp. 7–7. doi: 10.21037/atm.2017.11.06.

Bauersachs, R. M. (2023) ‘Fondaparinux Sodium: Recent Advances in the Management of Thrombosis’, Journal of Cardiovascular Pharmacology and Therapeutics, 28. doi: 10.1177/10742484221145010.

de Castillo, L. L. C. et al. (2021) ‘Cardiocerebral Infarction: A Single Institutional Series’, Journal of Stroke and Cerebrovascular Diseases, 30(7), pp. 1–8. doi: 10.1016/j.jstrokecerebrovasdis.2021.105831.

De Luca L, Uguccioni M, Natale E, Pugliese M, Terranova A, Biffani E, De Lio L, Piazza V, Putini RL, Musumeci F. Effectiveness of fondaparinux vs unfractionated heparin following percutaneous coronary intervention in survivors of out-of-hospital cardiac arrest due to acute myocardial infarction. European Journal of Clinical Pharmacology. 2021 Oct;77:1563-7.

Elkhader, B. A., Abdulla, A. A. and Ali Omer, M. A. (2016) ‘Correlation of smoking and myocardial infarction among sudanese male patients above 40 years of age’, Polish Journal of Radiology, 81, pp. 138–140. doi: 10.12659/PJR.894068.

Gregson, J. et al. (2019) ‘Cardiovascular Risk Factors Associated with Venous Thromboembolism’, JAMA Cardiology, 4(2), pp. 163–173. doi: 10.1001/jamacardio.2018.4537.

Hasan, T. F. et al. (2018) ‘Diagnosis and Management of Acute Ischemic Stroke’, Mayo Clinic Proceedings. Mayo Foundation for Medical Education and Research, 93(4), pp. 523–538. doi: 10.1016/j.mayocp.2018.02.013.

Ibanez, B. et al. (2018) ‘2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation’, European Heart Journal, 39(2), pp. 119–177. doi: 10.1093/eurheartj/ehx393.

Ibekwe, E., Kamdar, H. A. and Strohm, T. (2022) ‘Cardio-cerebral infarction in left MCA strokes: a case series and literature review’, Neurological Sciences. Springer International Publishing, 43(4), pp. 2413–2422. doi: 10.1007/s10072-021-05628-x.

Khan, M. Y. et al. (2022) ‘Fondaparinux: A cornerstone drug in acute coronary syndromes’, World Journal of Cardiology, 14(1), pp. 40–53. doi: 10.4330/wjc.v14.i1.40.

Lasica, R. et al. (2022) ‘Use of Anticoagulant Therapy in Patients with Acute Myocardial Infarction and Atrial Fibrillation’, Medicina (Lithuania), 58(3), pp. 1–14. doi: 10.3390/medicina58030338.

Nowbar, A. N. et al. (2019) ‘Mortality from ischemic heart disease: Analysis of data from the world health organization and coronary artery disease risk factors from NCD risk factor collaboration’, Circulation: Cardiovascular Quality and Outcomes, 12(6), pp. 1–11. doi: 10.1161/CIRCOUTCOMES.118.005375.

Omar, H. R. et al. (2010) ‘Concomitant acute right ventricular infarction and ischemic cerebrovascular stroke; Possible explanations’, International Archives of Medicine. BioMed Central Ltd, 3(1), p. 25. doi: 10.1186/1755-7682-3-25.

Powers, W. J. et al. (2018) 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association, Stroke. doi: 10.1161/STR.0000000000000158.

Poznyak, A. V. et al. (2022) ‘Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment’, Frontiers in Cardiovascular Medicine, 9(August), pp. 1–8. doi: 10.3389/fcvm.2022.959285.

Ricardo, Rigual., Jorge, Rodríguez-Pardo., Manuel, Lorenzo-Diéguez., Susana, Fernández-Fernández., Gabriel, Torres, Iglesias., Clara, Lastras., Gerardo, Ruiz-Ares., María, Alonso, de, Leciñana., Elena, De, Celis., Laura, Casado-Fernández., Carlos, Hervás., Elisa, Alonso., E., Díez-Tejedor., Blanca, Fuentes. Keeping prior anticoagulation treatment in the acute phase of ischaemic stroke: the REKOALA study.. Journal of Neurology, 2024. doi: 10.1007/s00415-024-12204-8

Roy A, Rawal I, Jabbour S, Prabhakaran D. Tobacco and cardiovascular disease: a summary of evidence. Cardiovascular, Respiratory, and Related Disorders. 3rd edition. 2017 Nov 17.

Shehadeh, M. et al. (2024) ‘Percutaneous coronary intervention can be safely performed with left ventricular thrombus without increasing stroke risk: A 5-year retrospective review using real-world data’, International Journal of Cardiology. Elsevier B.V., 395(June 2023), p. 131415. doi: 10.1016/j.ijcard.2023.131415.

Toluey, M. et al. (2019) ‘The impact of cigarette smoking on infarct location and in-hospital outcome following acute ST-elevation myocardial infarction’, Journal of Cardiovascular and Thoracic Research, 11(3), pp. 209–215. doi: 10.15171/jcvtr.2019.35.

Varmdal, T. et al. (2017) ‘Percutaneous Coronary Intervention as a Trigger for Stroke’, American Journal of Cardiology. Elsevier Ltd, 119(1), pp. 35–39. doi: 10.1016/j.amjcard.2016.09.012.

Yadav, V. et al. (2023) ‘A Rare Coexistence of Simultaneous Cardio-Cerebral Infarction’, Case Reports in Cardiology, 2023, pp. 1–5. doi: 10.1155/2023/9986712.

Zeus, T. et al. (2016) ‘Safety of percutaneous coronary intervention in patients with acute ischemic stroke/transient ischemic attack and acute coronary syndrome’, Clinical Research in Cardiology, 105(4), pp. 356–363. doi: 10.1007/s00392-015-0928-y.